Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 3Classical hematology 3Myeloid 2Lymphoid 2

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 213Precursor Cell Lymphoblastic Leukemia-Lymphoma 174Leukemia 163Lymphoma 148Lymphoma, Non-Hodgkin 142Leukemia, Myeloid, Acute 142Myelodysplastic Syndromes 132Hodgkin Disease 123Lymphoma, Follicular 111Lymphoma, Mantle-Cell 108Multiple Myeloma 105Lymphoma, Large B-Cell, Diffuse 96Lymphoma, B-Cell, Marginal Zone 89Burkitt Lymphoma 85Myeloproliferative Disorders 73Leukemia, Myelomonocytic, Chronic 63Congenital Abnormalities 63Leukemia, Myeloid, Chronic-Phase 62Lymphoma, Large-Cell, Immunoblastic 61Leukemia, Myeloid, Accelerated Phase 60Waldenstrom Macroglobulinemia 55Leukemia, Myelogenous, Chronic, BCR-ABL Positive 53Neoplasms, Plasma Cell 52Primary Myelofibrosis 48Recurrence 46Blast Crisis 44Anemia, Refractory, with Excess of Blasts 43Lymphoma, T-Cell, Cutaneous 42Dendritic Cell Sarcoma, Interdigitating 42Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 40

Interventions

fludarabine phosphate 2fludarabine 2Busulfan 2AP 1903 reagent 2Thiotepa 1Tacrolimus 1Mycophenolic Acid 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Melphalan 1Glucose Tolerance Test 1Cyclosporins 1Cyclophosphamide 1Continuous Glucose Monitoring 1Clofarabine 1Clinical Trials, Phase I as Topic 1Bone Marrow Transplantation 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hemoglobinopathies × fludarabine phosphate × Lymphoid × Clear all
NCT04644016 2026-03-13

Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
31 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Refractory, with Excess of Blasts, Hemoglobinopathies, Lymphoma, Non-Hodgkin, Myeloproliferative Disorders, Leukemia, Myeloid, Acute

NCT02061800 2024-06-04

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Columbia University

Phase 1/2 Active not recruiting
14 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Neutropenia, Severe Congenital, Autosomal Recessive 3, Bone Marrow Failure Disorders, Shwachman-Diamond Syndrome, Primary Immunodeficiency Diseases, Acquired Immunodeficiency Syndrome, Anemia, Aplastic, Anemia, Sickle Cell, Hemoglobinopathies, Histiocytosis, Langerhans-Cell, Lymphoma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Histiocytosis, Anemia, Diamond-Blackfan, Lymphohistiocytosis, Hemophagocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Macrophage Activation Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡